Effectiveness Trial of Attention Shaping for Schizophrenia
Effectiveness Trial of Attention Shaping for Schizophrenia
批准号:
7286756
负责人:
STEVEN M SILVERSTEIN
金额:
$45.59万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-14 至 2011-07-31
关键词:
AppendixAreaAttentionAttentional deficitBehaviorBehavior TherapyBehavioralCase StudyClassificationCognitionCognitiveCollectionCommunitiesConditionControlled StudyDailyDataData CollectionEducational InterventionEducational process of instructingEffectivenessEffectiveness of InterventionsEvaluationExploratory/Developmental Grant for Diagnostic Cancer ImagingFrequenciesGenerationsGoalsGoldGrowthHospital MovingHospitalizationImpairmentInterventionInterviewInvestigationLaboratoriesLearningLiteratureMaintenanceMeasuresMethodsModelingNegative FindingNeurocognitionNeurocognitiveNumbersOutcomeOutpatientsPatient Self-ReportPatientsPerformancePharmaceutical PreparationsProceduresPsychological reinforcementPublishingPurposeQuality of lifeRandomizedRangeRateReadinessRehabilitation therapyReportingResearchResearch PersonnelRoleRole playing therapySchizophreniaSelf EfficacySeriesShapesSocial FunctioningStandards of Weights and MeasuresStatistically SignificantTechniquesTimeTreatment outcomeWorkatypical antipsychoticbasecognitive functioncognitive rehabilitationeffectiveness trialexecutive functionfollow-upfunctional outcomesimprovedprogramspsychologicpsychosocialresponsesatisfactionsizeskill acquisitionskillsskills trainingsocial skillssuccesstheoriestreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Among people with schizophrenia, attentional impairment is a major barrier to being able to engage in, and learn new skills in, psychosocial skills training interventions. Therefore, developing methods to promote attentiveness and learning during skills training is an important step in improving treatment outcomes. Prior case reports, one controlled study, and data from an ongoing R21 application indicate that attention shaping procedures (ASP) are highly effective methods to achieve these goals. ASP is a manualized, behavioral intervention that involves individualized goal-setting, and standardized observational rating, prompting, and reinforcement procedures to assist patients in increasing the duration and quality of their attentiveness in psychosocial interventions. To date, studies of ASP have been limited in their outcome evaluations to in- group attentiveness and learning of group material. Other cognitive outcomes, generalizability, functional outcomes and durability of gains have not been studied. This proposal, therefore, describes a controlled effectiveness study of ASP that would comprehensively assess relevant outcomes, generalizability, functional skills related to those taught in the intervention and maintenance of the gains over six months. ASP will be integrated within a standard form of social skills training [UCLA Basic Conversation Skills Module (BCS)], and compared to a BCS-alone condition. Specific aims of the study involve examinations of: 1) the generalizability of ASP's effects to relevant domains of non-study-group attentiveness, and standardized measures of neurocognition; 2) functional outcomes involving social skills, as assessed through self-report, other-report, interview, and role-play based measures; and 3) the durability of ASP-associated gains, by conducting a 6-month follow-up assessment on all subjects. Statistical analyses will involve time-series and growth curve models that make use of daily in-group performance data to model treatment response. These data, plus more traditional analyses will determine whether, and to what extent, ASP confers advantages in attention, and learning and/or performance of behavioral skills to patients who receive it. The long-term objective of this project is to demonstrate that ASP can narrow the gap between the existence of potentially effective psychosocial interventions (such as skills training) and patients who, at present, cannot benefit from them due to attentional difficulties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Perceptual Organization Dysfunction as a Biomarker of Schizophrenia
-
批准号:8448253
-
项目类别:
-
资助金额:$21.03万
-
财政年份:2011
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Perceptual Organization Dysfunction as a Biomarker of Schizophrenia
-
批准号:8286859
-
项目类别:
-
资助金额:$40.79万
-
财政年份:2011
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Perceptual Organization Dysfunction as a Biomarker of Schizophrenia
-
批准号:8084304
-
项目类别:
-
资助金额:$46.45万
-
财政年份:2011
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Perceptual Organization Dysfunction as a Biomarker of Schizophrenia
-
批准号:8644920
-
项目类别:
-
资助金额:$42.99万
-
财政年份:2011
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Perceptual Organization Dysfunction as a Biomarker of Schizophrenia
-
批准号:8689515
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2011
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
3/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
-
批准号:7843170
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2010
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
3/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
-
批准号:7693814
-
项目类别:
-
资助金额:$12.21万
-
财政年份:2008
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium
-
批准号:10488752
-
项目类别:
-
资助金额:$22.51万
-
财政年份:2008
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
3/5 Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
-
批准号:8575169
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2008
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium
-
批准号:10452998
-
项目类别:
-
资助金额:$26.44万
-
财政年份:2008
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
3/5 Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium
-
批准号:10004738
-
项目类别:
-
资助金额:$49.36万
-
财政年份:2008
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
3/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium
-
批准号:7841797
-
项目类别:
-
资助金额:$12.26万
-
财政年份:2008
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Effectiveness Trial of Attention Shaping for Schizophrenia
-
批准号:7496958
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2006
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Effectiveness Trial of Attention Shaping for Schizophrenia
-
批准号:7668395
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2006
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Effectiveness Trial of Attention Shaping for Schizophrenia
-
批准号:7091007
-
项目类别:
-
资助金额:$44.64万
-
财政年份:2006
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Effectiveness Trial of Attention Shaping for Schizophrenia
-
批准号:7900369
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2006
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Shaping Attention in treatment--Refractory Schizophrenia
-
批准号:6831030
-
项目类别:
-
资助金额:$6.57万
-
财政年份:2003
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Shaping Attention in treatment-Refractory Schizophrenia
-
批准号:6889922
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2003
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Shaping Attention in treatment-Refractory Schizophrenia
-
批准号:6705032
-
项目类别:
-
资助金额:$17.29万
-
财政年份:2003
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
Shaping Attention in treatment--Refractory Schizophrenia
-
批准号:6574972
-
项目类别:
-
资助金额:$8.07万
-
财政年份:2003
-
负责人:STEVEN M SILVERSTEIN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: